他汀与糖尿病和溃疡性皮肤黑色素瘤诊断的关联
该横断面研究纳入787例新诊断临床IB或II期黑色素瘤患者,评估促炎因素及抗炎药物与溃疡性原发黑色素瘤的关联。194例溃疡性和593例非溃疡性患者中,规律使用他汀者溃疡性黑色素瘤诊断几率较低(OR 0.67,95%CI 0.45-0.99),调整后仍存在;在厚度≤2mm且核分裂≤2/mm2的亚组中,糖尿病患者溃疡性黑色素瘤诊断几率显著升高(OR 2.90,95%CI 1.07-7.90)。
要点
- 规律使用他汀与溃疡性原发黑色素瘤诊断几率降低相关。
- 糖尿病与溃疡性黑色素瘤诊断几率升高相关,尤其见于薄且低核分裂亚组。
- 结果支持全身炎症状态与抗炎药物可能影响溃疡性黑色素瘤诊断。
核心结论
- 他汀使用与溃疡性黑色素瘤诊断呈负相关,糖尿病与之呈正相关。
研究设计与样本
- 横断面研究纳入787例新诊断临床IB或II期黑色素瘤患者,其中溃疡性194例、非溃疡性593例。
主要发现
- 规律使用他汀者溃疡性原发黑色素瘤诊断几率较低(OR 0.67,95%CI 0.45-0.99),调整年龄、性别、厚度和核分裂后仍存在。
- 在厚度≤2mm且核分裂≤2/mm2的亚组(溃疡性40例,非溃疡性289例)中,糖尿病患者溃疡性黑色素瘤诊断几率显著升高(OR 2.90,95%CI 1.07-7.90),调整年龄、性别、BMI和他汀使用后。
关键数值与推荐
- 他汀使用与溃疡性黑色素瘤诊断的OR为0.67(95%CI 0.45-0.99)。
- 糖尿病与溃疡性黑色素瘤诊断的OR为2.90(95%CI 1.07-7.90),限于厚度≤2mm且核分裂≤2/mm2的亚组。
临床怎么用
- 临床评估黑色素瘤溃疡风险时,可关注患者他汀使用史和糖尿病状态。
局限性
- 横断面设计无法确定因果关系。
- 糖尿病与溃疡性黑色素瘤的显著关联仅见于厚度≤2mm且核分裂≤2/mm2的亚组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ulcerated primary melanomas are associated with an inflammatory tumor microenvironment. We hypothesized that systemic proinflammatory states and anti-inflammatory medications are also associated with a diagnosis of ulcerated melanoma. In a cross-sectional study of 787 patients with newly diagnosed clinical stage IB or II melanoma, we estimated odds ratios for the association of proinflammatory factors (high body mass index, diabetes, cardiovascular disease, hypertension, and smoking) or the use of anti-inflammatory medications (statins, aspirin, corticosteroids, and nonsteroidal anti-inflammatory drugs), with ulcerated primary melanoma using regression models and subgroup analyses to control for melanoma thickness and mitotic rate. On the basis of information from 194 patients with ulcerated and 593 patients with nonulcerated primary melanomas, regular statin users had lower likelihood of a diagnosis of ulcerated primary melanoma (odds ratio 0.67, 95% confidence interval 0.45-0.99), and this association remained after adjusting for age, sex, thickness, and mitosis. When analysis was limited to melanomas that were ≤2 mm thick and had ≤2 mitoses/mm2 (40 ulcerated; 289 without ulceration), patients with diabetes had significantly raised odds of diagnosis of ulcerated melanoma (odds ratio 2.90, 95% confidence interval 1.07-7.90), adjusted for age, sex, body mass index, and statin use. These findings support our hypotheses that statin use is inversely associated, and diabetes is positively associated, with ulcerated melanoma.
引用
- von Schuckmann LA, Smith D, Hughes MCB, et al. Associations of Statins and Diabetes with Diagnosis of Ulcerated Cutaneous Melanoma. J Invest Dermatol. 2017. PMID: 28842323. doi:10.1016/j.jid.2017.07.836
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。